,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-12-26 07:47:00,The Zacks Research Daily presents the best research output of our analyst team.,0.6325156092643738,0.012341027148067951,0.35514333844184875,positive,0.6201745867729187
1,2018-12-26 07:47:00,"Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Johnson & Johnson (JNJ) and Home Depot (HD).",0.042612627148628235,0.008425922133028507,0.9489614963531494,neutral,0.0341867059469223
2,2018-12-26 07:47:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
3,2018-12-26 07:47:00,"You can see all of today's research reports here >>>

Buy-ranked Amazon 's shares have outperformed the broader market year to date by a wide margin (the stock is up +14.9% vs. the -12% decline for the S&P 500 as a whole).",0.9277239441871643,0.04610912874341011,0.026166880503296852,positive,0.8816148042678833
4,2018-12-26 07:47:00,"The Zacks analyst thinks Amazon's strengthening retail position, with the help of its growing global footprint and distribution strength, remains its key growth driver.",0.9478121995925903,0.01509299036115408,0.03709487244486809,positive,0.9327192306518555
5,2018-12-26 07:47:00,"Moreover, robust Prime program and its benefits will continue to aid Amazon's retail business.",0.9392427206039429,0.014601691626012325,0.046155646443367004,positive,0.9246410131454468
6,2018-12-26 07:47:00,"Also, the rapid expansion of grocery services via Prime is a major positive.",0.9215119481086731,0.014758187346160412,0.06372988224029541,positive,0.9067537784576416
7,2018-12-26 07:47:00,"Additionally, the company's growing brick and mortar presence is a tailwind.",0.0814678743481636,0.8500711917877197,0.06846088171005249,negative,-0.7686033248901367
8,2018-12-26 07:47:00,"Further, increasing AWS regions and its growing adoption will continue to aid Amazon's cloud momentum.",0.9387527108192444,0.014130714349448681,0.04711655527353287,positive,0.9246219992637634
9,2018-12-26 07:47:00,"Also, a rising number of Alexa compatible devices is a major positive.",0.9177128076553345,0.01435326598584652,0.06793397665023804,positive,0.9033595323562622
10,2018-12-26 07:47:00,The company's growing initiatives are likely to aid its performance in the current holiday season.,0.9429108500480652,0.01458266843110323,0.04250643774867058,positive,0.9283281564712524
11,2018-12-26 07:47:00,"However, the management has lowered its sales outlook for this season due to changes in Indian holiday timing.",0.015746084973216057,0.9506974220275879,0.03355642408132553,negative,-0.9349513649940491
12,2018-12-26 07:47:00,"Also, rising cloud battle and heavy investment in fulfillment centers are headwinds.",0.02690240740776062,0.9481162428855896,0.02498144470155239,negative,-0.9212138652801514
13,2018-12-26 07:47:00,(You can read the full research report on Amazon here >>> ).,0.017570074647665024,0.016651075333356857,0.9657788276672363,neutral,0.0009189993143081665
14,2018-12-26 07:47:00,"Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals in the past six months, gaining +1% vs. +5.3%.",0.4574894309043884,0.5213969349861145,0.0211136844009161,negative,-0.06390750408172607
15,2018-12-26 07:47:00,J&J's Pharma segment is performing better than the market in 2018 despite the impact of biosimilars on Remicade sales.,0.9293774962425232,0.04418785497546196,0.026434652507305145,positive,0.8851896524429321
16,2018-12-26 07:47:00,"Also, the Medical Devices and Consumer units are seeing improving organic growth trends.",0.9470376968383789,0.014846541918814182,0.038115713745355606,positive,0.9321911334991455
17,2018-12-26 07:47:00,"Though quite a few key products in J&J's portfolio are facing generic competition, the Zacks analyst thinks new products in all segments, successful label expansion of cancer drugs like Imbruvica and Darzalex and contribution from recent acquisitions will continue to drive top-line growth.",0.9084347486495972,0.012109360657632351,0.07945597916841507,positive,0.896325409412384
18,2018-12-26 07:47:00,J&J enjoys a robust multi-year pipeline of new drugs and line extensions.,0.9192935824394226,0.013138441368937492,0.06756800413131714,positive,0.9061551690101624
19,2018-12-26 07:47:00,"Headwinds like generics, pricing pressure and soft global market conditions remain.",0.02310333028435707,0.9418946504592896,0.0350019708275795,negative,-0.9187912940979004
20,2018-12-26 07:47:00,Allegations that its talc/baby powders contain asbestos which causes the users to develop ovarian cancer have been an overhang on the stock's price lately.,0.027961311861872673,0.8896031379699707,0.08243555575609207,negative,-0.8616418242454529
21,2018-12-26 07:47:00,(You can read the full research report on Johnson & Johnson here >>> ).,0.013885675929486752,0.011374055407941341,0.9747402667999268,neutral,0.00251162052154541
22,2018-12-26 07:47:00,"Buy-ranked Home Depot 's shares have lost 18.9% in the past six months, marginally underperforming the Zacks Retail Building Products industry's 17% decline.",0.018832499161362648,0.9715459942817688,0.009621539153158665,negative,-0.9527134895324707
23,2018-12-26 07:47:00,"The company has a five-year long trend of beating earnings estimates, which continued in third-quarter fiscal 2018.",0.8670677542686462,0.06131531670689583,0.07161704450845718,positive,0.8057524561882019
24,2018-12-26 07:47:00,"Moreover, it has delivered positive sales surprise in eight out of the last nine quarters.",0.9543998837471008,0.020249996334314346,0.025350145995616913,positive,0.9341498613357544
25,2018-12-26 07:47:00,Results gained from strength in both professional and do-it-yourself categories.,0.9296019673347473,0.016380399465560913,0.05401766300201416,positive,0.9132215976715088
26,2018-12-26 07:47:00,It also benefits from positive customer response for assortments as well as enhancements to drive integrated shopping experience.,0.9375815987586975,0.014285357668995857,0.048133064061403275,positive,0.9232962131500244
27,2018-12-26 07:47:00,"The company is witnessing strength across store operations as well as digital portals, which reflect strong customer demand in the home improvement markets.",0.9434237480163574,0.014535797759890556,0.04204048216342926,positive,0.9288879632949829
28,2018-12-26 07:47:00,"Backed by solid year-to-date performance, the company raised its earnings and sales forecast for fiscal 2018.",0.9400414824485779,0.019124679267406464,0.04083377495408058,positive,0.9209167957305908
29,2018-12-26 07:47:00,"However, the company saw tough comps comparisons in the fiscal third quarter owing to impacts of hurricane-related sales gains in the prior year.",0.07144752144813538,0.9060474634170532,0.02250502072274685,negative,-0.8345999717712402
30,2018-12-26 07:47:00,Higher supply chain and transportation costs also continue to hurt margins.,0.01785552315413952,0.9682148694992065,0.013929581269621849,negative,-0.9503593444824219
31,2018-12-26 07:47:00,(You can read the full research report on Home Depot here >>> ).,0.012610534206032753,0.013505421578884125,0.973884105682373,neutral,-0.0008948873728513718
32,2018-12-26 07:47:00,"Other noteworthy reports we are featuring today include Medtronic (MDT), TD Ameritrade (AMTD) and Paychex (PAYX).",0.03682976961135864,0.005510193295776844,0.9576600790023804,neutral,0.03131957724690437
33,2018-12-26 07:47:00,"It's hard to believe, even for us at Zacks.",0.08736173063516617,0.254048228263855,0.6585900187492371,neutral,-0.1666865050792694
34,2018-12-26 07:47:00,"But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.",0.5075593590736389,0.04700726270675659,0.4454334080219269,positive,0.4605520963668823
35,2018-12-26 07:47:00,And this outperformance has not just been a recent phenomenon.,0.07535909861326218,0.015217346139252186,0.9094235301017761,neutral,0.060141753405332565
36,2018-12-26 07:47:00,Over the years it has been remarkably consistent.,0.6927107572555542,0.013971779495477676,0.29331743717193604,positive,0.6787389516830444
37,2018-12-26 07:47:00,"From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over.",0.7464389204978943,0.10755439102649689,0.14600670337677002,positive,0.6388845443725586
38,2018-12-26 07:47:00,Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.,0.5744941830635071,0.01052891369909048,0.41497692465782166,positive,0.5639652609825134
39,2018-12-26 07:47:00,Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.,0.1108352467417717,0.007436841260641813,0.881727933883667,neutral,0.1033984050154686
40,2018-12-26 07:47:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Previewreports.,0.026142945513129234,0.011532393284142017,0.9623246192932129,neutral,0.014610552228987217
41,2018-12-26 07:47:00,"If you want an email notification each time Sheraz publishes a new article, please click here>>>

The Zacks analyst is optimistic about the newly-closed buyout of Mazor Robotics which should fortify Medtronic's position in robotic spine surgery space.",0.8940731287002563,0.013597901910543442,0.0923289954662323,positive,0.8804752230644226
42,2018-12-26 07:47:00,"The stabilizing CRHF market also holds promise

The Zacks analyst believes TD Ameritrade is poised to growth through improving trading activities as DARTs continue to rise.",0.9525060057640076,0.016065094619989395,0.03142889589071274,positive,0.9364408850669861
43,2018-12-26 07:47:00,"Per the Zacks analyst, Heico's disciplined acquisition strategy supplements overall growth, including organic growth.",0.9454635381698608,0.014723457396030426,0.03981300815939903,positive,0.9307400584220886
44,2018-12-26 07:47:00,"Per the Zacks analyst growing international business and a diversified suite of trading products has led to high trading volumes, which are driving revenues.",0.9233558177947998,0.016331780701875687,0.0603124238550663,positive,0.9070240259170532
45,2018-12-26 07:47:00,"The Zacks analyst believes that buyout of BISAM has increased FactSet's international footprint, particularly in Europe.",0.9539610743522644,0.016285095363855362,0.029753852635622025,positive,0.937675952911377
46,2018-12-26 07:47:00,"According to the Zacks analyst, Jabil's top-line growth is benefiting from new contract wins in healthcare, automotive, cloud and 5G.",0.9511358141899109,0.015398851595818996,0.03346535935997963,positive,0.9357369542121887
47,2018-12-26 07:47:00,"Per the Zacks analyst, acquisition of GCA Services Group has strengthened ABM's long term operational and financial position.",0.9567265510559082,0.018617458641529083,0.02465609274804592,positive,0.9381090998649597
48,2018-12-26 07:47:00,The Zacks analyst appreciates the company's efforts to modernize its fleet.,0.9222118854522705,0.01641891896724701,0.061369284987449646,positive,0.9057929515838623
49,2018-12-26 07:47:00,Efforts to reward shareholders are also commendable.,0.7917755246162415,0.01451462134718895,0.19370988011360168,positive,0.7772608995437622
50,2018-12-26 07:47:00,"Per the Zacks analyst, BlackBerry's strong software business, which benefits from a comprehensive service portfolio, should enhance operating cash flow.",0.9539083242416382,0.016246572136878967,0.029845086857676506,positive,0.9376617670059204
51,2018-12-26 07:47:00,The Cylance buyout will help to boost growth.,0.9439520239830017,0.018785709515213966,0.03726226091384888,positive,0.9251663088798523
52,2018-12-26 07:47:00,"The Zacks analyst believes that acquisition of Oasis will aid Paychex in boosting its professional employer organizations (PEO) growth strategy, strengthening client base and improving revenue growth.",0.9540241956710815,0.016932599246501923,0.02904316410422325,positive,0.937091588973999
53,2018-12-26 07:47:00,"Per the Zacks analyst, Principal Financial's escalating expenses, mainly due to operating as well as higher benefits, claims and settlement costs, will continue to restrict operating margin expansion.",0.048309728503227234,0.919562816619873,0.032127492129802704,negative,-0.8712530732154846
54,2018-12-26 07:47:00,"The Zacks analyst is worried about the slowdown in the Permian Basin activities amid the pipeline takeaway constraints, which is likely to be a drag on Halliburton's fourth-quarter earnings.",0.023682083934545517,0.9270939230918884,0.04922403767704964,negative,-0.903411865234375
55,2018-12-26 07:47:00,The Zacks analyst believes that high debt may limit TransUnion's future expansion and worsen its risk profile.,0.02933518774807453,0.9406545758247375,0.030010195448994637,negative,-0.911319375038147
56,2018-12-26 07:47:00,Seasonality causes considerable fluctuations in revenues.,0.018566595390439034,0.3923254609107971,0.5891079306602478,neutral,-0.37375885248184204
57,2018-12-26 07:47:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
58,2018-12-26 07:47:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
59,2018-12-26 07:47:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
60,2018-12-26 07:47:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
